MiRisten
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MiRisten, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]